Tag: pharmaceuticals
-
Gates Grant Awarded for Tuberculosis Genomics Research
The Infectious Disease Research Institute (IDRI) in Seattle, Washington, said today it received a multi-million dollar grant from the Bill and Melinda Gates Foundation for research in chemical genomics to identify targets and leads in tuberculosis (TB). The project includes access to a large library of compounds at Eli Lilly and Company. The grant aims…
-
U.K. Partnership to Test Cancer Drug Combinations
Cancer Research U.K., a London-based organization supporting cancer research, has signed an agreement with the global pharmaceutical company AstraZeneca to take combinations of experimental cancer drugs into early phase clinical trials. The trials will be held at hospitals in the U.K. taking part in the Experimental Cancer Medicine Centre (ECMC) Network. The agreement is expected…
-
Partnership Will Develop Green Training for Pharmacists
University of the Sciences in Philadelphia, Pennsylvania and Practice Greenhealth (PGH) in Reston, Virgina will collaborate to develop and promote sustainability training for pharmacists, pharmacy students, and related professionals. PGH is a membership organization for institutions in health care that have made a commitment to environmentally-friendly practices. The university and PGH will develop training modules…
-
Sanofi-Aventis to Support UCSF Research Program
The French pharmaceutical company Sanofi-aventis said today it will take part in a program at the University of California, San Francisco (UCSF) that encourages innovative biomedical research. Sanofi-aventis will be the first industry partner in UCSF’s Program for Breakthrough Biomedical Research that awards funding to projects of potentially high impact and greater creativity. Sanofi-aventis will…
-
Danish Pharma Company Restructures, Cuts Workforce
NeuroSearch, a biopharmaceutical company in Copenhagen, Denmark said today the company would restructure its operations to focus more on developing drugs for the central nervous system. This reorganization of the enterprise, says NeuroSearch, will lead to a 20 percent reduction in its workforce. The goal of the restructuring is to accelerate development of its lead…
-
Nanotech Helps Reduce Cancer Drug Side Effects
Researchers at MIT in Cambridge, Massachusetts and Brigham and Women’s Hospital in Boston have shown that they can use nanotechnology to deliver the cancer drug cisplatin much more effectively and safely. Cisplatin (illustrated right) has been approved by the FDA as a treatment alone for bladder and ovarian cancer, and with other therapies for a…
-
Eli Lilly, Boehringer Ingelheim to Partner on Diabetes Drugs
Pharmaceutical manufacturers Eli Lilly and Company in Indianapolis and Boehringer Ingelheim in Germany have agreed to jointly develop and commercialize several of their diabetes compounds in mid- and late-stage development. The total value of the deal could reach $2.37 billion. The agreement covers Boehringer Ingelheim’s two oral diabetes agents — linagliptin and BI10773 — and…
-
Consortium to Develop Sanfilippo B Gene Therapy
Amsterdam Molecular Therapeutics (AMT), a biopharmaceuticalcompany in the Netherlands, and a group of French research institutes, including the Institut Pasteur in Paris, has formed a consortium to develop a gene therapy to treat Sanfilippo B. AMT will manufacture compounds to be tested in a clinical trial of the therapy. Sanfilippo B is a rare genetic…
-
Myeloma Foundation Awards Biotech Research Grants
The Multiple Myeloma Research Foundation (MMRF) in Norwalk, Connecticut today announced awards of $1 million to each of three Massachusetts biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals Inc., Epizyme Inc., and Karyopharm Therapeutics Inc. Since the biotech program began in 2006, MMRF funded research at 11 companies leading to treatments for…
-
Spirogen, Genentech Partner on Anti-Cancer Therapies
Spirogen Ltd. a London, U.K. biotechnology company, announced a multi-year research collaboration and license agreement with Genentech, a Roche Group company, to discover and develop antibody drug conjugates (ADCs) as potential anti-cancer agents. The collaboration will make use of Spirogen’s pyrrolobenzodiazepine (PBD) drugs, a group of natural antibiotics, and associated linking technology. Under the agreement,…